This inventor holds 1 USPTO granted patent. Top assignee: Avant Immunotherapeutics, Inc.. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Karen Metcalfe: Innovator in Herpes Virus Research
Introduction
Karen Metcalfe is a notable inventor based in Wilmington, MA (US). She has made significant contributions to the field of virology, particularly in the development of cell lines that support the replication of Herpes Simplex Virus strains. Her work is crucial for advancing vaccine research and therapeutic strategies.
Latest Patents
Karen Metcalfe holds a patent for a cell line capable of supporting the replication of a growth-defective Herpes Simplex Virus strain, specifically a replication-defective HSV-2 double mutant. This innovative cell line expresses the ICP8 protein and the UL5 protein of Herpes Simplex Virus. It is particularly useful for propagating a replication-defective HSV-2 vaccine strain that contains mutations and/or deletions in the ICP8 and UL5 genes. She has 1 patent to her name.
Career Highlights
Karen Metcalfe is associated with Avant Immunotherapeutics, Inc., where she applies her expertise in virology and cell line development. Her work at the company focuses on creating innovative solutions for viral infections, contributing to the advancement of immunotherapeutic strategies.
Conclusion
Karen Metcalfe's contributions to herpes virus research and her innovative patent highlight her role as a significant figure in the field of virology. Her work continues to pave the way for advancements in vaccine development and therapeutic interventions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile